자가 섬유아세포-히알루론산 복합체를 이용한 당뇨발의 치료
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 엄수진 | - |
dc.contributor.author | 한승규 | - |
dc.contributor.author | 구자혜 | - |
dc.contributor.author | 정성호 | - |
dc.contributor.author | 김우경 | - |
dc.date.accessioned | 2021-09-09T00:08:38Z | - |
dc.date.available | 2021-09-09T00:08:38Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 2234-6163 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121822 | - |
dc.description.abstract | Purpose: To evaluate clinical efficacy and safety of hyaluronic acid based autologous dermal fibroblasts (Hyalograft 3D) in the treatment of diabetic foot ulcers. Methods: A total of 28 patients with diabetic ulcers were randomized to either the control group with nonadherent foam dressings(n=14) or the treatment group with autologous tissue-engineered grafts(n=14). Weekly assessment contained vital sign checks, ulcer size measurements, and wound photos. In the 12th week, percentages of complete wound healing and mean healing times were compared. Safety was also monitored by adverse events. Results: Complete wound healing was achieved in 84.6% of the treatment group and 23.1% of the control group(p<0.005). The mean times of closures for the treatment versus control groups were 6.1 weeks and 10.9 weeks, respectively. No adverse events related to the study treatment occurred. Conclusion: The use of hyaluronic acid based autologous fibroblast grafts was found to be a safe and effective treatment for diabetic foot ulcers. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한성형외과학회 | - |
dc.title | 자가 섬유아세포-히알루론산 복합체를 이용한 당뇨발의 치료 | - |
dc.title.alternative | Treatment of Diabetic Ulcer using Autologous Fibroblast-Hyaluronic Acid Complex | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 한승규 | - |
dc.identifier.bibliographicCitation | Archives of Plastic Surgery, v.36, no.5, pp.548 - 554 | - |
dc.relation.isPartOf | Archives of Plastic Surgery | - |
dc.citation.title | Archives of Plastic Surgery | - |
dc.citation.volume | 36 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 548 | - |
dc.citation.endPage | 554 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001375540 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Diabetic foot | - |
dc.subject.keywordAuthor | Fibroblast cell therapy | - |
dc.subject.keywordAuthor | Hyaluronic acid | - |
dc.subject.keywordAuthor | Diabetic foot | - |
dc.subject.keywordAuthor | Fibroblast cell therapy | - |
dc.subject.keywordAuthor | Hyaluronic acid | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.